Geraldine Murphy, Managing Director LEO Pharma UK/IE introduces the organisation.
At LEO Pharma UK/Ireland (UK/IE), we aim to lead the way in establishing patient support programmes and joint working initiatives in our specialist areas. We also carry out clinical studies globally on behalf of the LEO Pharma group.
We’re truly passionate about driving innovation. Like the rest of our global company, LEO Pharma UK/IE is ultimately owned by the LEO Foundation. With no shareholders, we can invest more in research and development and advancing care for people who need it most.
At LEO Pharma UK/IE, we aim to lead the way in driving patient-focused and partnership approach to our activities. Our patient focused approach, combined with a distinct business model driven by our independent LEO Foundation ownership and knowledge of the UK and Irish markets make us a truly unique company.
Coupled with this, our combination of innovative thinking and integrity also explains why LEO Pharma was the second company globally to declare its commitment to clinical data transparency in 2013. We continue to champion and drive leadership in this area in the UK.
Read about our Corporate social responsibility.